Mulmit

Vaxart, Inc.Vaxart, Inc.

VXRT OTC

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2025-12-31237,258,00018,074,00016,3270.07
2024-12-3128,700,000-66,293,000-66,948-0.33
2023-12-317,379,000-83,347,000-82,465
2018-12-314,159,000-21,756,000-18,007,000
2017-12-315,839,000-10,015,000-9,582,000

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-07-16Finney Kevin39,400
2026-07-16Finney Kevin78,700
2026-07-16BREITMEYER JAMES B8,315
2026-07-16BREITMEYER JAMES B16,610
2026-07-16HERON ELAINE J39,400
2026-07-16HERON ELAINE J78,700
2026-07-16Watson W. Mark39,400
2026-07-16Watson W. Mark78,700
2026-07-16Wheadon David E.39,400
2026-07-16Wheadon David E.78,700
2026-05-22Watson W. Mark10,000
2026-05-19Grasman Jeroen NicolaasChief Financial Officer31,395

8-K events

FiledItems
2026-08-25Other events
2026-08-06Results of operations · Financial statements and exhibits
2026-07-28Other events
2026-07-17Submission of matters to a vote · Regulation FD disclosure · Financial statements and exhibits
2026-07-07Other events · Financial statements and exhibits
2026-07-02Entry into a material agreement · Regulation FD disclosure · Financial statements and exhibits
2026-06-26Entry into a material agreement · Other events · Financial statements and exhibits
2026-05-19Other events · Financial statements and exhibits
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

Biological Products, (No Diagnostic Substances) — 같은 업종, 그리고 규모가 비슷한 기업Biological Products, (No Diagnostic Substances) — and other companies of a similar size

SEC가 같은 업종(Biological Products, (No Diagnostic Substances))으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (Biological Products, (No Diagnostic Substances)) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.